跳至主要内容
临床试验/ISRCTN15626850
ISRCTN15626850已完成1 期

Prospective study to improve cardiorespiratory performance and muscle strength in patients with cystinosis using the Galileo vibration plate

Cystinose Stiftung0 个研究点目标入组 40 人开始时间: 2023年9月21日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Confirmed diagnosis of infantile nephropathic cystinosis
  • 2. Prepubertal patients from 6 to 13 years of age or from the age of 18
  • 3. Consent of the patient (18 years and older) or legal representative (for minors)

排除标准

  • 1. Patients who are likely to undergo a serious intervention (e.g. kidney transplant, orthopedic surgery) during the duration of the study or for whom there are contraindications for training on Galileo vibration platforms according to the official recommendation
  • 2. Adolescents who have started puberty (boys: testicular volume 3 ml, girls: Tanner stage from B2). Since puberty in these patients starts late, the prepubertal age group was extended to the age of 13 years. The pubertal age group was excluded due to the hormonal changes during this period.

研究者

相似试验